Investors include Versant, ARCH Venture Partners, Prospect Venture Partners, JAFCO, Partner Funds, INVUS Financial Advisors, BBT Capital Management Apothecary Capital, and Altitude Life Science Ventures. Also joining the syndicate were Foley Ventures and Latham and Watkins.
Read More